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Effects of furosemide on low-dose mercuric chloride acute renal
failure in the rat. The use ofpotent diuretics in acute renal failure
remains controversial. Both beneficial and detrimental effects have
been reported. In the present study, the effects of both low and
high doses of furosemide administered in the developmental and
established stages of mercuric chloride-induced acute renal failure
were evaluated. Both low and high doses of furosemide produced a
significant diuresis when given early in the course of experimental
acute renal failure. Despite this diuresis, furosemide did not mod-
ify the development of the acute renal failure. Continued adminis-
tration of a low dose of furosemide had no effect on renal function;
however, prolonged administration of high doses of furosemide
resulted in significantly lower creatinine clearances 48 hr after
induction of acute renal failure. This detrimental effect was due to
sodium depletion by the diuretic since it was prevented by contin-
uous replacement of urinary sodium losses. In the absence of so-
dium depletion, high doses of furosemide produced a significant
diuresis, both in the developmental and established phases of acute
renal failure, but it had no effect on the degree of renal functional
impairment.
Effets de Ia furosémide sur l'insuffisance rénale aiguë du rat induite
par des doses faibles de chlorure mercurique. L'emploi de diuré-
tiques puissants dans l'insuffisance rénale aigue demeure discuté.
Dans cc travail ont été étudiés les effets de doses faibles et de doses
importantes de furosémide administróes soit précocément, au stade
d'installation, soit plus tardivement au cours de l'insuffisance ré-
nale due au chlorure mercurique. Les doses faibles aussi bien que
les doses élevées produisent une diurse significative quand dIes
sont administrées tot au cours de l'insufflsance rénale expérimen-
tale. Malgré cette diurèse, Ia furosémide ne modifie pas Ic déve-
loppement de l'insuffisance rénale. L'administration continue de
faibles doses de furosémide n'a pas d'effet sur Ia fonction rénale
alors que l'administration prolongée de fortes doses de furosémide
aboutit a des clearences de Ia créatinine significativement in-
férieures 48 heures après l'induction de l'insuffisance rénale. Cet
effet néfaste est du 0 Ia déplétion en sodium déterminée par Ic
diurétique et il disparait quand les pertes urinaires de sodium sont
systématiquement compensées. En l'absence de déplétion en so-
dium, des doses importantes de furosémide produisent une diurèse
significative, 0 Ia fois au stade précoce de l'insuffisance rénale aiguë
et après son établissement, mais dIes n'ont pas d'effet sur Ic degré
d'altération de Ia fonction rénale.
The administration of potent diuretics in the clini-
cal setting of oliguria has become common practice
[1-6]. While a diuretic response may be helpful in
differentiating pre-renal azotemia from established
renal failure, there are occasions when urine flow
increases after the administration of furosemide but
renal function remains impaired. In this latter situa-
tion, it has been suggested that the diuretic has con-
verted the renal failure to a milder form [2, 3]. In
contrast, other studies have suggested that furose-
mide may worsen acute renal failure, both clinically
and experimentally, when it is used concurrently with
other nephrotoxic agents [7-10].
Cantarovich et al [11, 12] have reported that con-
tinued treatment with high doses of furosemide in
established acute renal failure will hasten the onset of
diuresis and shorten the duration of uremia. How-
ever, this beneficial effect has not been confirmed in
other clinical studies [13] nor has it been confirmed in
experimental animal studies in which high doses of
furosemide were given after the induction of acute
renal failure [14]. Thus, the ability of furosemide to
modify the course of acute renal failure, whether ad-
ministered during its developmental stages or after it
has become established, remains controversial.
The present study, performed in rats, was designed
to observe the effects of repeated doses of furosemide
at 12 and 48 hr after the induction of acute renal
failure with 4.7 mg/kg of body wt mercuric chloride.
The objectives of this study were to answer the follow-
ing questions: 1. Does furosemide, when given early
in acute renal failure, modify its development? 2. Is
any beneficial or detrimental effect of furosemide in
acute renal failure dose-dependent? 3. Does furose-
mide, when given in repetitive low or high doses,
result in earlier recovery of renal function?
Methods
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Studies were performed in female Sprague-Dawley
rats weighing between 200 and 250 g. The animals
Furosemide and acute renal failure 363
were housed in individual metabolic cages with free
access to rat chow (Purina) and tap water.
Acute renal failure was induced by i.m. injection of
4.7 mg/kg of body wt mercuric chloride (HgCI2) in a
concentration of 6.0 mg/ml. Furosemide was admin-
istered i.m. in doses of 1.14, 10 or2O mg/kg of body
wt beginning one hour after HgC12 injection and re-
peated at six-hour intervals until sacrifice of the ani-
mals. The concentration of furosemide was 10 mg/
ml.
Two sets of experiments were conducted to deter-
mine renal function at 12 and at 48 hr after HgCI2
administration. Endogenous creatinine clearances
were used as a measure of renal function. The pro-
tocol for the 48-hr studies is depicted in Fig. 1. The
12-hr studies were identical except urine was collected
under mineral oil for clearance studies from 0 to 12 hr
and the animals were killed at 12 hr. In the 48-hr
studies, urine was collected under mineral oil for the
24 hr prior to sacrifice. Blood was collected by in-
tracardiac puncture at the time of sacrifice while the
animal was under sodium pentobarbital anesthesia.
The following groups of animals were studied:
Group I: normal controls. Isotonic saline, 0.15 to 0.2
ml i.m., was given in place of HgCI2 at time zero plus
0.02 to 0.5 ml of isotonic saline i.m. in place of furose-
mide at 1 hr and subsequent 6-hr intervals until sacri-
fice at either 12 or 48 hr.
Group II: HgC12 plus saline placebo. At time zero
HgCI2, 4.7 mg/kg, was given i.m. followed by a pla-
cebo injection, 0.02 to 0.5 ml of isotonic saline i.m., in
place of furosemide at one hour and subsequent six-
hour intervals until sacrifice.
Group III. low dose furosemide. This group is the
same as group II, except 1.14 mg/kg of furosemide
was given at one hour and subsequent six-hour inter-
vals.
Group IV: high dose furosemide. This group is the
same as group III, except each dose of furosemide
was 10 or 20 mg/kg of body wt. Since the results with
10 mg/kg and 20 mg/kg were identical, these animals
have been grouped together.
Time, hr Protocol
01 7 13 19 25 31 37 43 48
+ + + + t + +
F F F F F F F Sacrifice
or or or or or or or
P P P P P P P
Clearance
Fig. 1. Protocol of experimental maneuvers. HgCl2 4.7 mg/kg of
mercuric chloride administered i.m. P = isotonic sodium chloride,
F = furosemide, clearance = 24-hr urine collections under mineral
oil for determination of endogenous creatinine clearance.
Group V: sodium replacement. This group is identical
to group IV except urinary sodium losses of the pre-
ceding six hours were replaced by i.p. injection of
isotonic saline solution. The average amount of so-
dium lost and replaced was 0.55 mEq/l0O g of body
wt (range, 0.46 to 0.62 mEq/100 g) every six hours.
Two more groups of animals were studied to deter-
mine the effects of low and high doses of furosemide
alone on kidney function.
Group VI. At time zero, 0.15 to 0.2 ml of isotonic
saline was given i.m. followed by 1.14 mg/kg of fu-
rosemide at one hour and subsequent six-hour inter-
vals until sacrifice at 48 hr.
Group VII. This group is the same as group VI except
20 mg/kg of furosemide was administered per dose.
Serum and urine were analyzed simultaneously for
creatinine by the Jaffe reaction, and urea nitrogen on
an autoanalyzer (Technicon) [14, 15]. Serum and
urine sodium concentrations were measured by flame
photometry with lithium as the internal standard.
The creatinine clearance was calculated in the conven-
tional manner and corrected to 100 g of body wt.
Statistical analysis was performed using the unpaired
Student's I test.
Results
Effect offurosemide on HgCl2 acute renal failure 12
hr after induction. The mean values of 12-hr urine
volume (V), endogenous creatinine clearance (Ccr),
serum concentration of creatinine (Scr), urea nitro-
gen (Sun) and sodium (SNa) in the 12-hr studies are
shown in Table 1. When compared to group I control
animals, group II animals given 4.7 mg/kg of HgCl2
had significantly lower mean Ccr (0.70 0.08 vs. 0.31
0.03 ml/min/l00 g, P < 0.01) and higher mean Scr
(0.6 0.03 vs. 1.0 0.13 mg/lOO ml, P < 0.05).
There was no significant difference in the urine vol-
ume or SNa (P> 0.05) in these two groups of animals.
Group III animals given furosemide, 1.14 mg/kg,
one and seven hours after HgCI2 administration had
a higher urine volume compared to group II animals
given HgCI2 plus saline placebo (18.3 3.3 vs. 8.3
1.8 ml/l2 hr, P < 0.02). However, there were no
significant differences in the Ccr (P > 0.5), Scr or SNa
(P> 0.1).
Animals given high doses of furosemide after
HgCl2 administration (group IV) had a significantly
higher 12-hr urine volume when compared to control
animals (26.2 2.1 vs. 8.3 1.8 ml/12 hr, P <
0.001). There was no difference in the mean Ccr be-
tween animals with HgCl2-induced acute renal failure
who were subsequently given high-dose furosemide
HgC12 F
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compared to those given saline placebo or low-dose
furosemide (P > 0.5). However, the SNa was signifi-
cantly lower in group IV high-dose furosemide ani-
mals compared to the other groups (P < 0.05).
It is possible that sodium depletion following high
doses of furosemide may have obscured beneficial
effects of the diuretic on the development of acute
renal failure. Thus, in group V animals, urine Na
losses after high-dose furosemide were replaced by
i.p. injection of saline at six-hour intervals. The mean
S in this group was significantly higher compared
to group IV animals (132 0.3 vs. 127 1.0 mEq/
liter, P < 0.05) as was urine volume (P < 0.02).
However, there was no difference in the Ccr and Scr
in this group compared to all but the normal group I
animals (P > 0.5).
Thus, in rats with HgCl2-induced acute renal fail-
ure, the early administration of low or high doses of
furosemide resulted in a significant diuresis but
endogenous creatinine clearance was not altered at
12 hr. It is possible that the period of observation was
too brief for changes in renal function to be observed.
Effects offurosemide on HgCI2 acute rena/failure 48
hr after induction. Furosemide, in low or high doses,
was given exactly as described in the 12-hr experi-
ments but continued at 6-hr intervals until sacrifice at
48 hr. The results of these studies are shown in Table
2. There was no difference in the Ccr and Scr in
animals given HgCI2 plus low doses of furosemide
(group III) compared to group II control animals
that had received HgC12 plus saline placebo (P >
0.2). However, body weight was significantly lower in
the furosemide-treated animals at 48 hr. The absence
of significant hyponatremia and the high Sun out of
proportion to the Scr suggests dehydration as a cause
of the weight loss, even though the animals had free
serum creatinine, S..,,, = mean
change from beginning to the
access to water. Thus, continued treatment with low
doses of furosemide did not alter the degree of the
renal functional impairment when measured at 48 hr.
Rather, these animals became dehydrated but not to
a degree to cause a further decrease in Ccr.
In the group IV animals who received high doses of
furosemide, the mean Ccr was significantly lower
than allother groups (0.02 0.01 ml/min/lOOg, P <
0.01). Also, the Scr was significantly higher (6.7 0.4
mg/lOO ml, P < 0.01), and the SNa significantly lower
(120 1.4 mEq/liter, P < 0.02) compared to all
other groups. Thus, early and repeated high doses of
furosemide had a detrimental effect on the course of
the acute renal failure as measured at 48 hr. Also of
note was that three animals in the high-dose furose-
mide group died in the second 24 hr of treatment.
The development of significant hyponatremia in
the group IV animals suggested that excessive sodium
losses were responsible for the enhancement of the
renal failure. In group V animals, urinary sodium
losses were replaced every six hours by i.p. injections
of saline containing the exact amount of sodium lost
in the urine in the preceding six hours. This group
had a significantly higher urine volume (47.4 11.4
ml/l2 hr) when compared to all other groups (P <
0.01). The Scr, Sun, Ccr and SNa were not signifi-
cantly different from animals given HgCl2 plus saline
placebo (group IL) or HgC12 plus low-dose furose-
mide (group III). Thus, early and repeated adminis-
tration of high-dose furosemide caused a more severe
decrement in renal function in HgCI2-induced renal
failure at 48 hr. This effect was abolished by replacing
urinary sodium losses during the study period.
Effects of furosemide in normal animals at 48 hr.
Control animals were given an initial injection of
isotonic sodium chloride instead of HgCI2 and
Table 1. Effect of early and repeated low or high doses of furosemide on the development of acute renal failure at 12 hr
Groups N
V
ml/I2hr
Ccr
mI/min/JOOg
Sor
mg/lOOm!
S,,
mg/lOO ml
SN
mEq/liter
Wt, g, zero
hrtosacrifice
I Normal controls 7 5.4 07b 0.70± 0.08 0.6 0.03c 21 1.7 142 2
II HgCl2 plus salineplacebo 6 8.3 1.8 0.31 0.03 1.0 0.13 29 3.6 138 1.0 1lii HgCl2plus 1.14 mg/kg of
furosemide every 6 hr 6 18.3 33d 0.29 0.04 1.0 0.10 36 3.5 134 0.9 —8
IV 1-IgCl2 plus 10 or 20 mg/
kg of furosemide every
6 hr 14 26.2 2.1" 0.29 0.03 1.1 0.10 60 4.8 127 l.0c
V Same as IV except UN,,
losses replaced every 6hr 7 43.0 2.8 0.26 0.03 1.1 0.10 45 4.0 132 0.3 —5
V = urine volume/12 hr, Ccr = mean endogenous creatinine clearance, S,, = mean concentration of
concentration of serum urea nitrogen, SN,, = mean concentration of serum sodium, wt g = weight
end of the study.
b Mean SEM.
° P < 0.05 when compared to all other groups.
d P < 0.02 when compared to group TI.
P < 0.01 when compared to all other groups.
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Table 2. Effect of repeated low or high doses of furosemide on acute renal failure at 48 hr6
Groups N
V
mI/24 hr
Car
,nl/min/IOO g
Scr
mg/100 ml
S.,
mg/100 ml
S
mEq/liter
Wt, Ag, zero
hr to sacrifice
I Normal controls 8 13,3 1,4b 0.62 0.1° 0.51 0.Olr 20.1 0.7° 138 0.4 +4
11 HgCl plus salineplacebo 23 18.6 3.1 0.14 0.03 3.3 0.5 162 27.0 136 3.0 —3
Ill HgCl2plus 1.14 mg/kg of
furosemide every 6hr 7 15.3 6.6 0.10 0.06 3.8 0.9 211 49 133 3.0 —23
IV HgCl2 plus 10 or 20 mg/
kg" of furosemide every
6 hr 23 9.6 5.2 0.02 0.Ole 6.7 0.4° 280 17 120 + 1.40 —8
V Same as IV except UN8
losses replaced everf6hr 6 47.4 11.4° 0.13 0.05 3.3 0.7 130 25 133 0.7 5
a Abbreviations are the same as in Table 1.
bMean + SEM.
P < 0.01 when compared to other groups.
"Three animals in this group died before the 48-hr study period was completed.
P < 0.02 when compared to all other groups.
treated 1 hr later with either a low dose (group V) or
a high dose (group VII) of furosemide which was
repeated every 6 hr prior to sacrifice at 48 hr. There
were no significant differences in the mean Ccr, Scr
and SNa of both groups of animals when compared to
control animals (P > 0.5) (Table 3).
Discussion
The use of potent diuretics has been advocated in
the clinical setting of oliguria of recent onset [1-5]. If
a diuresis occurs after the use of these drugs, without
deterioration of renal function, it is assumed that the
oliguria was due to pre-renal factors. In the absence
of obstruction, severe volume depletion or cardio-
vascular insufficiency, the lack of a diuretic response
would suggest the presence of damage to the renal
parenchyma. Continued treatment with furosemide
will occasionally result in an increase in urine output
but with continued renal functional impairment. It
has been suggested by Franklin and Maxwell [2] and
Kjellstrand [3] that this response may be due to the
ability of the diuretic to convert the renal failure into
a milder form. There have been no controlled studies
in humans to determine whether the development of
acute renal failure is modified by the early use of
diuretics. Experimental studies in dogs have given
conflicting results. Montoreano et al [17] studied the
effects of furosemide, 8 mg/kg i.v., given in the first
and second hour after methemoglobin-induced acute
renal failure. Urine volume, urine sodium excretion
and glomerular filtration rate were higher in the
treated animals compared to the control group three
hours after induction. Muth [18] also found higher
urine sodium excretion at three hours after giving 15
mg/kg of furosemide i.v. in the same model, although
there was no difference in glomerular filtration rate as
measured by inulin clearance. These studies show
that urine volume is higher with the use of diuretics in
experimental acute renal failure, but do not confirm a
favorable effect of the drugs on renal function.
Another area of controversy is the value of repeti-
tive doses of potent diuretics after renal failure has
become established. Cantarovich et al [11, 12] have
reported that repeated high doses of furosemide, up
to 3 g/day, were beneficial in the treatment of
patients with established acute renal failure of mul-
tiple etiologies. The treated patients had an earlier
diuresis, shorter duration of uremia and fewer dial-
yses compared to untreated patients. However, other
Table 3. Effect of early and repeated low and high doses of furosemide in normal animals at 48 hr6
Groups
V
ml/24 hr
Cer
ml/min/100 g
Sr
mg/IOO ml
S,,8
mg/IOO ml
SN8
mEq/iiter
Wt, Ag, zero
hr to sacrifice
I Normal controls 8 13.3 14b 0.62 0.1 0.51 0.1 20.1 139 0.4 +4
VI Salineplus 1.14 mg/kgof
furosemideevery6hr 7 18.4 1.5 0.58 0.1° 0.5 0.1° 25 1.0 137 —2
VI! Saline plus 20mg/kg of
furosemideevery6hr 9 29.4 2.0 0.63 0.05° 0.6 25 1.0 138 + 1.0° —6
8 Abbreviations are the same as in Table 1.
b Mean SEM.
P value > 0.05 when compared to group 1.
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clinical studies have not confirmed these results [13].
Foord and Dodds reported that furosemide en-
hanced the nephrotoxicity of some antibiotics [7, 8].
Interpretation of these studies is difficult since renal
failure was of multiple etiologies, different doses of
furosemide were used and other therapeutic inter-
ventions were used concomitantly with furosemide.
The present study was undertaken to evaluate the
effect of furosemide on the course of mercuric chlo-
ride-induced acute renal failure in rats. Mercuric chlo-
ride, 4.7 mg/kg administered i.m., results in nonoli-
guric acute renal failure which allows collection of
urine for measurement of endogenous creatinine
clearance. Twelve hours after HgCl2 injection, there
was a significant decrease in the endogenous creati-
nine clearance and the kidneys showed minimal histo-
logic lesions of proximal tubular necrosis. The cre-
atinine clearance was further decreased by 48 hr and
there were definite histologic lesions of acute tubular
necrosis. The mechanism(s) responsible for the de-
crease in glomerular filtration rate in this model may
be due to a decrease in total renal blood flow partic-
ularly to the outer cortex [20]. However, some ele-
ment of tubular obstruction or tubular back diffusion
cannot be ruled out [21].
In addition to its potent diuretic properties, furose-
mide has been shown to increase total renal blood
flow [22, 23] and cortical blood flow [24] in experi-
mental animals. Theoretically, furosemide may be
beneficial in acute renal failure if it 1) prevents or
corrects the vasomotor changes and 2) alleviates or
prevents tubular obstruction by establishing a diur-
esis.
In the present study animals given early and re-
peated low or high doses of furosemide had signifi-
cantly higher urine volumes in the first 12 hr after
induction of acute renal failure. However, neither low
nor high doses of furosemide modified the decrement
in creatinine clearance compared to animals given
mercuric chloride alone (Table 1),
Further studies were performed to evaluate
whether continued treatment with furosemide could
modify the duration of the renal failure as suggested
by Cantaroviciret al [11, 12]. Low or high doses of
furosemide were given 1 hr after injections of mer-
curic chloride and every 6 hr until sacrifice at 48 hr.
Low doses of furosemide had neither a beneficial nor
a detrimental effect on the acute renal failure. How-
ever, early and repeated high doses of furosemide
(group IV) resulted in a worsening of the renal failure
when compared to animals given mercuric chloride
alone (Table 2). These findings are similar to those of
Lawson et al [9, 10] and Linton et al [14] who docu-
mented a detrimental effect of high doses of furose-
mide given in combination with nephrotoxic anti-
biotics. The mechanism(s) of this detrimental effect
have not been elucidated.
Studies were conducted to rule out a direct nephro-
toxic effect of furosemide (Table 3). The renal func-
tion in these animals was no different from control
animals at 48 hr, and the kidneys were normal histo-
logically. These results ruled out the possibility that
repeated high doses of furosemide as used in the pres-
ent study were directly toxic to normal renal tubules.
However, the possibility that furosemide was acting
synergistically with HgCl2 to enhance the acute renal
failure could not be discounted.
In the animals in which renal impairment was en-
hanced with furosemide, there was an associated
hyponatremia and weight loss. Replacement of urine
sodium losses in animals treated with high doses of
furosemide corrected the hyponatremia and pre-
vented the further impairment of renal function.
These data imply that sodium depletion, secondary to
diuretics, enhances the acute renal failure. However,
even with the replacement of the sodium losses, there
is no beneficial effect of repeated high doses of furose-
mide on renal function 48 hr after induction of acute
renal failure in this model.
The present study does not provide data on the
potential beneficial effect of furosemide given before
the induction of acute renal failure. Bailey et al [25]
have shown a protective effect in animals treated with
furosemide prior to exposure to nephrotoxic anti-
biotics or HgCl2. The mechanisms responsible for
this modifying effect require further study.
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